Allogene Therapeutics Inc. (ALLO) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
4:04 pm
Purchase
2021-02-1613GAllogene Therapeutics, Inc.
ALLO
Capital International Investors7,699,703
5.500%
7,699,703increase
(New Position)
Filing
History
2021-02-16
3:46 pm
Purchase
2021-02-1613GAllogene Therapeutics, Inc.
ALLO
Capital Research Global Investors12,640,338
9.000%
6,097,660increase
(+93.20%)
Filing
History
2021-02-12
2:32 pm
Sale
2020-12-3113GAllogene Therapeutics, Inc.
ALLO
Arie Belldegrun, M.D.6,494,493
4.600%
-859,507decrease
(-11.69%)
Filing
History
2021-02-12
1:00 pm
Sale
2020-12-3113GAllogene Therapeutics, Inc.
ALLO
Seaview Trust7,340,867
5.200%
-1,251,741decrease
(-14.57%)
Filing
History
Goto Prev, 0, 1, 2